Abstract 1510: CASTLE: long-read sequencing panel of cancer cell lines to improve standards of somatic variant calling and benchmarking

Abstract Most current large-scale whole-genome sequencing projects rely on short-read sequencing to call germline and somatic SVs, however it provides an incomplete view of the somatic variation landscape because of mappability limitations. In contrast, long-read sequencing can resolve highly repetitive regions of the human genome, and assemble variants into contiguous haplotypes, and therefore is a promising approach to resolve the hidden complexity of a cancer genome. However there is still a limited number of publicly available datasets for benchmarking and development of new methods. To motivate the development of new short- and long-read tools for cancer genomics, we created the CASTLE panel, based on multi-technology whole-genome sequencing of six commercially available tumor/normal cell line pairs (HCC1954, HCC1937, H1437, H2009, Hs578T and HCC1395). The panel represents two lung and three breast cancer cell lines. Genomic sequencing currently includes PacBio, Oxford Nanopore, Illumina, Hi-C and PoreC, in most cases sequenced from the same DNA extraction or cell line passage. We further generated high-confidence benchmarking somatic variant calls for SNPs, small indels and structural variants using the ensemble method. For structural variants, We used Severus, nanomonsv, SAVANA, Sniffles2, SvABA, GRIDSS, and Manta to generate initial variant calls; confident calls were defined if supported by at least two (out of three) technologies and at least 4 (out of 11) callers. For small variant benchmarking sets, we used a combination of Strelka2, DeepSomatic and ClairS. Overall, we release a new public resource for cancer genomic developments and benchmarking, which we are aiming to complement with additional genomic and transcriptomic technologies. The data and benchmarking datasets are openly available at: https://github.com/CASTLE-Panel/castle. Citation Format: Mikhail Kolmogorov, Ayse Gokce Kesus, Asher Bryant, Tanveer Ahmad, Byunggil Yoo, Sergey Aganezov, Anton Goretsky, Ataberk Donmez, Lisa Lansdon, Joshua Gardner, Brandy McNulty, Samuel Sacco, Jyoti Shetty, Yongmei Zhao, Bao Tran, Giuseppe Narzisi, Adrienne Hellend, Chengpeng Bi, Adam Walter, Margaret Gibson, Irina Pushel, Erin Guest, Tomi Pastinen, Nicolas Robine, Karen H. Miga, Midhat S. Farooqi, Benedict Paten. CASTLE: long-read sequencing panel of cancer cell lines to improve standards of somatic variant calling and benchmarking [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 1510.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-1510
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 1510: CASTLE: long-read sequencing panel of cancer cell lines to improve standards of somatic variant calling and benchmarking

Ataberk Donmez, Bao Tran, Brandy McNulty, Anton Goretsky et al.
Cancer Research
Cancer Genomics and Diagnostics
article

Abstract 1510: CASTLE: long-read sequencing panel of cancer cell lines to improve standards of somatic variant calling and benchmarking

Ataberk Donmez, Bao Tran, Brandy McNulty, Anton Goretsky, Nicolas Robine, Mikhail Kolmogorov, Yongmei Zhao, Midhat S. Farooqi, Erin Guest, Benedict Paten, Sergey Aganezov, Giuseppe Narzisi, Ayse Gokce Kesus, Jyoti Shetty, Asher Bryant, Chengpeng Bi, Adrienne Hellend, Irina Pushel, Samuel Sacco, Adam Walter, Karen H. Miga, Margaret Gibson, Byunggil Yoo, Tomi Pastinen, Tanveer Ahmad, Lisa Lansdon, Joshua Gardner
article en

Abstract

Abstract Most current large-scale whole-genome sequencing projects rely on short-read sequencing to call germline and somatic SVs, however it provides an incomplete view of the somatic variation landscape because of mappability limitations. In contrast, long-read sequencing can resolve highly repetitive regions of the human genome, and assemble variants into contiguous haplotypes, and therefore is a promising approach to resolve the hidden complexity of a cancer genome. However there is still a limited number of publicly available datasets for benchmarking and development of new methods. To motivate the development of new short- and long-read tools for cancer genomics, we created the CASTLE panel, based on multi-technology whole-genome sequencing of six commercially available tumor/normal cell line pairs (HCC1954, HCC1937, H1437, H2009, Hs578T and HCC1395). The panel represents two lung and three breast cancer cell lines. Genomic sequencing currently includes PacBio, Oxford Nanopore, Illumina, Hi-C and PoreC, in most cases sequenced from the same DNA extraction or cell line passage. We further generated high-confidence benchmarking somatic variant calls for SNPs, small indels and structural variants using the ensemble method. For structural variants, We used Severus, nanomonsv, SAVANA, Sniffles2, SvABA, GRIDSS, and Manta to generate initial variant calls; confident calls were defined if supported by at least two (out of three) technologies and at least 4 (out of 11) callers. For small variant benchmarking sets, we used a combination of Strelka2, DeepSomatic and ClairS. Overall, we release a new public resource for cancer genomic developments and benchmarking, which we are aiming to complement with additional genomic and transcriptomic technologies. The data and benchmarking datasets are openly available at: https://github.com/CASTLE-Panel/castle. Citation Format: Mikhail Kolmogorov, Ayse Gokce Kesus, Asher Bryant, Tanveer Ahmad, Byunggil Yoo, Sergey Aganezov, Anton Goretsky, Ataberk Donmez, Lisa Lansdon, Joshua Gardner, Brandy McNulty, Samuel Sacco, Jyoti Shetty, Yongmei Zhao, Bao Tran, Giuseppe Narzisi, Adrienne Hellend, Chengpeng Bi, Adam Walter, Margaret Gibson, Irina Pushel, Erin Guest, Tomi Pastinen, Nicolas Robine, Karen H. Miga, Midhat S. Farooqi, Benedict Paten. CASTLE: long-read sequencing panel of cancer cell lines to improve standards of somatic variant calling and benchmarking [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 1510.

Cancer ResearchVol. 86(7_Supplement)
Children's Mercy Hospital (US), University of California, Santa Cruz (US), National Cancer Institute (US), Mercy Research (US), Santa Cruz County Office of Education (US), New York Genome Center (US), Oxford Nanopore Technologies (United Kingdom) (GB), Mercy Hospital (US)
Openalex Percentile: Top 30%
Cancer Genomics and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.